1. 월가를 뒤흔든 25세 AI 천재 레오폴드의 포트폴리오 : 반도체 숏과 AI 인프라 집중 투자 반도체 숏 포지션 및 헤징 전략: Situational Awareness LP가 NVIDIA, AMD, Broadcom, TSMC 등 주요 반도체 기업 및 SMH ETF에 대한 대규모 Put 옵션 포지션을 공시하며 단기 밸류에이션 과열에 대비한 숏 포지션 구축.병목 레이어 대상 Long 포지션 재배치: 반도체 숏 포지션과 달리 CoreWeave, SanDisk 등 AI 클라우드 컴퓨팅 및 메모리/스토리지 병목 레이어 기업의 Long 포지션을 신규 매수하며 선택적 자본 집적 달성.AI 장기 신념과 단기 밸류에이션의 분리: 슈퍼지능에 대한 장기적 신념과...

Ex-OpenAI Researcher’s Fund Shorts Major Semis While Doubling Down on Selected AI Infrastructure.Leopold Aschenbrenner, a former OpenAI researcher and founder of Situational Awareness LP, revealed a striking portfolio reallocation in his fund's Q1 2026 filing. Despite being one of the industry's most vocal AI bulls, Aschenbrenner’s fund disclosed substantial put (short) positions against major semiconductor leaders while selectively accumulating long positions in specific AI infrastructure players such as CoreWeave and SanDisk.Bearish / Pu...

AI agents are moving from centralized systems toward a decentralized network of trillions of personal and organizational agents.The real business opportunity isn’t building agents for specific tasks — it’s building the marketplaces, protocols, and services that agents will need.A new MIT research initiative called Project NANDA is working to keep the agentic web open before corporate consolidation makes that impossible.MIT’s Ramesh Raskar offers a compelling vision of the future. Suppose a 70-year-old pre-diabetic woman from rural India...

Finding organic growth in today's volatile business landscape has become more challenging than ever, prompting global corporate leaders to elevate venture building into a central growth strategy.A July 2026 report published in McKinsey Quarterly, titled The CEO's Critical Role in Building New Businesses, reveals that despite mounting cost pressures and economic uncertainty, approximately 40 percent of global chief executive officers continue to rank new-business building as one of their top three strategic priorities. In fact, when surveyed...

The deluge of articles, presentations, and press releases on the applications of AI techniques to drug discovery does not make it easy to tell just what those applications are and how useful they might be (at least so far). This is an excellent new article from a number of people who know what they’re talking about in the field and who (importantly) are not trying to sell you anything, either.Its authors point out (correctly, I’d say) that the evidence for real clinical impact so far is very thin:“Although a wide variety of AI methods hav...

Running Is Becoming A Luxury Lifestyle.US running apparel sales climbed 10% to nearly $1B, while sales of $150+ running shoes jumped 46%, per Circana.As run clubs and finisher medals signal identity and status, participation has expanded beyond logging miles — with some runners now spending nearly $1.5K/year on apparel, shoes, gear, race entries, nutrition, and subscriptions.Beyond technical gear, brands like @satisfyrunning, @bandit, and @districtvision built subcultures around taste, community, and belonging. Executing premium playbooks,...

Surging consumer demand for experimental peptides is outpacing existing safety research and regulatory oversight in the US.Telemedicine firms and clinics are lobbying to legalise distribution pathways, despite warnings that unproven drugs pose health risks.Political pressure to expand access is at odds with the opinion of medical experts.Dr. Anant Vinjamoori was at home enjoying his morning coffee when one of his doctor group chats lit up. A friend had seen something horrifying in Queens: a standard corner bodega, its windows stuffed with ad...

IDP-001 is a bispecific antibody-drug conjugate targeting EGFR and a novel Tumor-Associated Proximity Antigen identified through InduPro’s proximity-guided platform.Phase 1 study is enrolling adults with advanced squamous non-small cell lung cancer and other solid tumorsFinancing led by The Column Group, with participation from Vida Ventures, MRL Ventures Fund, Emerson Collective (advised by Yosemite), Euclidean Capital, Solasta Ventures, Sanofi, and Eli Lilly and CompanyInduPro, Inc., a biotechnology company defining membrane protein spati...

Over the past few years, smartphone improvements have become increasingly incremental with recent launches mostly improving cameras, screens and battery tech rather than introducing genuinely new features. The only notable break in that pattern has been the emergence of on-device AI features that promise smarter assistants and easy-to-use creative tools. However, even those features are not yet the gamechangers that marketing would suggest.When asked by Statista Consumer Insights what matters most to U.S. smartphone users, the top answers ar...